Mitsukuchi M, Ikemoto T, Taguchi M, Higuchi S, Abe S, Yasui H, Hatayama K, Sota K
Chem Pharm Bull (Tokyo). 1989 Jul;37(7):1795-801. doi: 10.1248/cpb.37.1795.
As part of the search for new topical antiinflammatory agents, various 21-substituted corticosteroids having sulfur-containing moieties were prepared and tested for vasoconstrictive activity in humans. A structure-activity relationship study revealed that substitution of the 21-hydroxy group with a lower alkyl-thio group enhanced the activity. The activities of the 21-methylthio (3Ad) and the 21-ethylthio (3Ae) compounds were more potent than that of 9 alpha-fluoro-11 beta,21-dihydroxy-16 beta-methyl-17 alpha-valeroyloxy-1,4- pregnadiene-3,20-dione (betamethasone 17-valerate, BV).
作为寻找新型局部抗炎药的一部分,制备了各种含硫部分的21-取代皮质类固醇,并对其在人体中的血管收缩活性进行了测试。结构-活性关系研究表明,用低级烷硫基取代21-羟基可增强活性。21-甲硫基(3Ad)和21-乙硫基(3Ae)化合物的活性比9α-氟-11β,21-二羟基-16β-甲基-17α-戊酰氧基-1,4-孕二烯-3,20-二酮(倍他米松17-戊酸酯,BV)更强。